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We describe here a specific calcineurin activity in
neutrophil lysates, which is dependent on Ca21, inhib-
ited by trifluoroperazine, and insensitive to okadaic
acid. Immunoblotting experiments using a specific anti-
serum recognized both the A and B chains of cal-
cineurin. Neutrophils treated with cyclosporin A or FK
506 showed a dose-dependent inhibition of calcineurin
activity. The effect of oxidant compounds on calcineurin
activity was also investigated. Neutrophils treated with
hydrogen peroxide (H2O2), where catalase was inhibited
with aminotriazole, exhibited a specific inhibition of
calcineurin activity. However, the addition of reducing
agents to neutrophil extracts partially reversed the in-
hibition caused by H2O2. A similar inhibitory effect of
H2O2 on calcineurin activity was observed to occur in
isolated lymphocytes. This is the first demonstration
that redox agents modulate calcineurin activity in a
cellular system. In addition, electrophoretic mobility
shift assays revealed that lipopolysaccharide-induced
activation of NF-kB in human neutrophils is inhibited
by cell pretreatment with H2O2 in a dose-dependent
manner. These data indicate that calcineurin activity
regulates the functional activity of lipopolysaccharide-
induced NF-kB/Rel proteins in human neutrophils.
These data indicate a role of peroxides in the modula-
tion of calcineurin activity and that the H2O2-dependent
NF-kB inactivation in neutrophils occurs in concert
with inhibition of calcineurin.
Calcineurin (CN)1 has recently been established as a key
enzyme in the signal transduction cascade leading to T cell
activation (1–4), and an important regulator of transcription
factors such as NF-AT, NF-kB, and AP-1, which are involved in
the expression of a number of important T cell early genes, i.e.
interleukin-2, tumor necrosis factor-a, and interleukin-2R (5–
8). CN, also known as phosphatase 2B, is a calcium/calmodulin-
dependent serine/threonine phosphatase (9–11) and is com-
posed of the following two subunits: a 59-kDa catalytic subunit
(CNA), which contains a calmodulin-binding domain and an
autoinhibitory region, and a 19-kDa intrinsic calcium-binding
regulatory subunit (CNB) (12–14). Human CN possesses a
Fe-Zn active center. The assignment of stoichiometric amounts
of Zn21 and Fe31 in the CNA center is based on atomic absorp-
tion experiments (15). The same assignments were made for
the di-metal site in the structure of some CNA (16).The central
role of CN in T cell signaling was appreciated by its identifica-
tion as the target of the immunosuppressive drugs cyclosporin
A (CsA) and FK 506 (1–4). The phosphatase activity of CN is
inhibited by either drug when complexed to intracellular bind-
ing proteins (immunophilins), i.e. CsA to cyclophilin and FK
506 to the FK 506-binding protein 12 (FKBP12), respectively.
Neither drug nor immunophilin alone bind to or affect the
activity of CN (1). This phosphatase is expressed ubiquitously
in eukaryotic cells. In mammals, CN is most abundant in the
brain (17) but has also been detected in T cells (1–4). On the
other hand, it is known that NF-AT-mediated transactivation
depends on the CN activity (18, 19). Other findings suggest
that NF-kB activity is also under CN control (20–22).
In neutrophils, only indirect evidence has been presented on
the occurrence of the phosphatase CN. The treatment of these
cells with inhibitors of CN (e.g. CsA and FK 506) inhibited the
neutrophils chemokinesis on vitronectin matrix (23, 24). Fur-
thermore, intracellular calcium and CN regulate neutrophil
motility on vitronectin through a receptor identified by anti-
bodies against the integrins av and b3 (25, 26). The first pur-
pose of the present work was to assess the presence of CN in
neutrophils using as a substrate a specific peptide correspond-
ing to the phosphorylation site of the RII subunit of cyclic
AMP-dependent protein kinase.
Additionally, reactive oxygen intermediates (ROI) have been
implicated in mediating signal transduction by a variety of
stimuli in lymphoid cells, and transcription factors seem to be
responsible for the inducible expression of a number of genes in
response to oxidative stress (27, 28). In this context, the addi-
tion of H2O2 to the culture medium has been shown to activate
NF-kB (29). Hydroxyl radicals produced from H2O2 cannot
function as diffusible intracellular messengers, since they can
react with the nearest molecule in a nonspecific fashion. A
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more suitable ROI messenger would be the less reactive H2O2.
However, arguments against ROI involvement in NF-kB acti-
vation have been published (30–32), and despite the fact that
phorbol 12-myristate 13-acetate-dependent NF-kB stimulation
is cancelled by antioxidants, it has been recently shown that
phorbol 12-myristate 13-acetate does not increase intracellular
ROI (33). Peroxide-mediated stimulation of NF-kB appears to
be cell line-specific, since N-acetylcysteine, an antioxidant, elic-
ited up-regulation of NF-kB binding activity in monocyte-de-
rived macrophages (34). Moreover, NF-kB is not the only nu-
clear factor whose activity is altered by H2O2. In a fashion
opposite to that observed for NF-kB, NF-AT has been shown to
be actively suppressed by H2O2 in Jurkat T cells (35). Recently,
the development of stabilized peroxovanadium compounds has
provided the opportunity to more fully characterize the action
of oxidants within the cell (36). Treatment of lymphocytes with
sodium oxodiperoxo(1,10-phenanthroline)vanadate (V), pV-
(phen), results in a large increase in intracellular oxidation,
which correlates with a strong induction of cellular tyrosine
phosphorylation and activation of kinases. The same authors
(37) have documented that antioxidant treatment does not
prevent the activation of NF-kB by pV(phen). Therefore, we
have also used pV(phen) as another tool to study the effect of
oxidative stress on calcineurin activity.
In summary, previous data suggest that, first, CN modulates
the DNA binding activity of essential transcription factors (e.g.
NF-AT and NF-kB), and second, ROI regulates positively or
negatively those transcription factors. However, a link between
both signals, that is CN and ROI, is lacking. In this paper we
address this question and the implications of the ROI as uni-
versal messenger to activate NF-kB.
EXPERIMENTAL PROCEDURES
Cell and Reagents—Neutrophils were isolated from fresh hepa-
rinized blood of healthy human donors by dextran sedimentation, fol-
lowed by Ficoll-Paque gradient centrifugation and hypotonic lysis of
residual erythrocytes as indicated (38). Neutrophils were washed twice
in Hanks’ balanced salt solution (HBSS), suspended at a density of 1 3
107 cells/ml in HBSS supplemented with 0.1 mg/ml BSA, and main-
tained at 37 °C in an atmosphere of 5% CO2 and 95% O2 for 1–2 h.
Peripheral blood lymphocytes were obtained from heparinized venous
blood of normal volunteers by Ficoll-Paque centrifugation.
Dextran T-500 was obtained from Pharmacia Biotech (Barcelona,
Spain). Ficoll-Paque, HBSS, and RPMI 1640 were obtained from Bio-
Whittaker (Verviers, Belgium). CsA and FK 506 were kindly provided
by Dr. S. F. Borel (Sandoz Ltd., Basel, Switzerland) and Fujisawa
GmbH (Mu¨nchen, Germany), respectively. Chemicals were of analytical
grade from Merck (Darmstadt, Germany). Dithiothreitol (DTT) and
phenylmethylsulfonyl fluoride (PMSF) were obtained from Boehringer
Mannheim (Barcelona, Spain). Bovine serum albumin (BSA), okadaic
acid, trifluoroperazine, pyrrolidine dithiocarbamate (PDTC), hydrogen
peroxide (30% v/v), 3-amino-1,2,4-triazole (aminotriazole, AMT), soy-
bean trypsin inhibitor, leupeptin, aprotinin, Nonidet P-40, and goat
anti-rabbit IgG conjugated to horseradish peroxidase were purchased
from Sigma (Madrid, Spain). Rabbit anti-bovine calcineurin IgG was
kindly provided by C. B. Klee. The synthetic peptide used as a substrate
for calcineurin was purchased from Peninsula Laboratories (Bellmont,
CA). pV(phen) was synthesized as described previously (37). [g-32P]ATP
was obtained from NEN Life Science Products. 2-Mercaptoethanol,
SDS, acrylamide, N,N9-methylene-bisacrylamide, Coomassie Brilliant
Blue R-250, and blotting nitrocellulose membranes were purchased
from Bio-Rad. Luminol (5-amino-2,3-dihydro-1,4-phthalazinedione) and
diisopropyl fluorophosphate (DFP) were purchased from Serva (Madrid,
Spain), and 4-iodophenol was from Aldrich (Madrid, Spain). Molecular
weight standards (Rainbow markers) was obtained from Amersham
Corp. (London, UK); Sephadex G-25 was from Pharmacia (Barcelona,
Spain); and double-stranded oligonucleotide probe (59-AGTTGAG GG-
GACTTTCC CAGGC-39) containing NF-kB sites was from Boehringer
Mannheim Gmbh (Mannheim, Germany). 29,79-Dichlorodihydro-fluo-
rescein diacetate (H2DCFDA) was purchased from Molecular Probes
(Leiden, The Netherlands).
Crude Neutrophils Extract—Untreated neutrophils (1 3 108 cells/ml)
were lysed for 30 min on ice in 500 ml of buffer A (50 mM Tris, pH 8.0,
0.5% Triton X-100, 150 mM NaCl, 50 mg/ml PMSF, 50 mg/ml soybean
trypsin inhibitor, 10 mg/ml leupeptin, and 10 mg/ml aprotinin) and
disrupted by sonication. The homogenate was centrifuged at 12,000 3 g
for 10 min at 4 °C. The supernatant fluid (crude extract) was separated
from low molecular weight material by passage through a 0.5 3 10-cm
Sephadex G-25 column equilibrated with 50 mM Tris-Cl, pH 7.5, 0.1 mM
EDTA, 0.1% b-mercaptoethanol, and a mixture of protease inhibitors as
above (39). Fractions containing most of the A280 nm material eluting
with the void volume of the column were pooled and used to measure
CN activity.
Cell Treatments and Lysis—Immunosuppressive agents were dis-
solved in dimethyl sulfoxide (Me2SO) at a concentration 1000-fold
higher than that used for cell treatments. Neutrophils (7 3 106 cells/ml)
were suspended in 1 ml of HBSS supplemented with 0.1 mg/ml BSA in
microcentrifuge tubes, 1 ml of Me2SO or CsA or FK 506 was added, and
the cells were incubated at 37 °C for 2 h. For experiments with H2O2
and other stimuli, neutrophils were incubated at 37 °C. The incubation
times and concentration of agents are indicated in the figure legends.
After incubation, the cells were washed once with 1 ml of HBSS on ice
and lysed in 60 ml of buffer B (50 mM Tris, pH 7.5, 0.1 mM EGTA, 1 mM
EDTA, 0.5 mM dithiothreitol, 50 mg/ml PMSF, 50 mg/ml soybean trypsin
inhibitor, 10 mg/ml leupeptin, and 10 mg/ml aprotinin) and disrupted by
sonication. Cell debris was removed by centrifugation at 4 °C for 10 min
at 12,000 3 g, and supernatant was used as the source of CN.
Calcineurin Phosphatase Assay—CN phosphatase activity was meas-
ured using an assay adapted from Hubbard and Klee (40), basically as
described (22). Neutrophils (7 3 106 cells/ml) were incubated for 2 h at
37 °C in the presence or absence of drugs as indicated in the text.
Reaction mixtures containing 2 mM 32P-labeled phosphopeptide, 500 nM
okadaic acid (added to inhibit PP-1A and PP-2A type phosphatase
activities), and 20 ml of cell lysate (about 80 mg of protein) were incu-
bated in a total volume of 60 ml of assay buffer C (20 mM Tris, pH 8.0,
100 mM NaCl, 6 mM MgCl2, 0.5 mM dithiothreitol, and 0.1 mM CaCl2 or
5 mM EGTA, as indicated in the figures) for 15 min at 30 °C. After this
time, reactions were terminated by the addition of 0.5 ml of 100 mM
potassium phosphate buffer, pH 7.0, containing 5% trichloroacetic acid.
The reaction mixture was passed through a 500-ml column of activated
Dowex cation-exchange resin, and free inorganic phosphate was quan-
titated in the eluate by scintillation counting. It was verified that at 15
min of incubation time the assay was linear. Assays were performed in
triplicate, and the counts/min measured in blank assay lacking cell
lysate were subtracted. Data are expressed as the number of picomoles
of 32PO4 released in 15 min per mg of protein.
32P-Labeled Phosphopeptide—The synthetic peptide (Asp-Leu-Asp-
Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Ala-Ala-Glu),
corresponding to a segment of the RII subunit of cAMP-dependent
kinase (41), was phosphorylated on the unique serine residue by the
catalytic subunit of cAMP-dependent protein kinase using [g-32P]ATP,
essentially as described (40), and used as phosphatase substrate. The
specific activity of fresh preparations of 32P-labeled phosphopeptide was
about 500 mCi/mmol peptide.
Western Blot Analysis—Cells (7 3 106 cells/ml) were lysed for 30 min
on ice in 100 ml of buffer A (see above). Lysates were clarified by
centrifugation at 4 °C for 2 min at 12,000 3 g. Protein concentrations in
the lysates were determined by the Bradford method (42), using BSA as
a standard. For the Western blot analysis of CN subunits A and B,
neutrophil lysates were subjected to 12.5% SDS-PAGE followed by
electroblotting onto nitrocellulose using the Bio-Rad Mini-blotting ap-
paratus. Filters were blocked for 1 h in TBS (150 mM NaCl, 50 mM
Tris-HCl, pH 7.5) containing 3% BSA. Furthermore, they were rinsed
twice with TBS containing 0.1% Tween 20 (TBST), and they were
incubated overnight with rabbit anti-bovine calcineurin IgG diluted
1:1000 in TBST. After three washes in TBST, the filters were incubated
for 90 min with horseradish peroxidase-conjugated goat anti-rabbit IgG
(1:5000, final dilution). Filters were then washed twice with TBS and
then twice with TBST for 10 min each time. The bound secondary
antibody was detected by enhanced chemiluminescence (43). Briefly,
the membranes were incubated for 1 min in 10 ml of fresh luminescent
reagent solution, composed of 10 mM Tris-HCl, pH 8.5, 2.25 mM luminol,
0.015% (v/v) H2O2, and 0.45 mM 4-iodophenol, the latter acting as an
enhancer of the chemiluminescence reaction (44). These concentrations
of luminol, H2O2, and 4-iodophenol were determined to be optimal for
maximum light production.2 Luminol and 4-iodophenol were freshly
prepared in 10 ml of 10 mM Tris-HCl, pH 8.5. Luminol was previously
dissolved in 50 ml of 1 M NaOH. The use of Me2SO as solvent should be
2 M. Carballo and F. Sobrino, unpublished data.
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avoided since in alkaline/Me2SO conditions, luminol autoxidizes with
emission of intense luminescence (45). After 1 min of incubation, the
membranes were placed on paper filter, covered with Saran Wrap, and
exposed to x-ray films (X-Omat, Eastman Kodak Co.) in the dark for 1–5
min.
Electrophoretic Mobility Shift Assays (EMSA)—Human neutrophils
whose viability exceeded 98% after 3 h in culture, as determined by
trypan blue exclusion, were resuspended at a density of 5 3 106 cells/ml
in RPMI 1640 medium supplemented with 10% fetal calf serum. The
cells were then incubated at 37 °C under a 5% CO2 atmosphere for 3 h,
with occasional shaking in the absence or presence of 1 mg/ml LPS, 1
mg/ml CsA, or H2O2 at the concentrations indicated in each experiment.
Then nuclear extracts were prepared basically as described by Mc-
Donald et al. (46). With this purpose, cell suspensions were transferred
into pre-cooled tubes containing an equivalent volume of ice-cold RPMI
1640 supplemented with DFP (2 mM, final concentration). After centrif-
ugation at 4,000 3 g for 1 min at 4 °C, the cells were resuspended in 100
ml of ice-cold relaxation buffer, consisting of 10 mM HEPES, pH 7.3, 30
mM KCl, 3 mM NaCl, 3.5 mM MgCl2, 1.25 mM EGTA, and 0.5 mM DTT,
supplemented with an antiprotease mixture composed of 2 mM DFP, 1
mM PMSF, 10 mM iodoacetamide, 1 mM benzamidine, and 10 mg/ml each
of aprotinin, leupeptin, and captopril. Cells were disrupted by short
sonication (1 s), and the lysates were spun at 3,000 3 g for 10 min at
4 °C to pellet unbroken cells and intact nuclei. The pellets were resus-
pended in 100 ml of ice-cold relaxation buffer, again subjected to short
(1 s) sonication, and respun as above to pellet intact nuclei. These were
resuspended in 200 ml of relaxation buffer, and after new centrifuga-
tion, the nuclear pellet was resuspended in 25 ml of ice-cold relaxation
buffer, additionally containing 10% (v/v) glycerol and 380 mM NaCl.
Following a 20-min incubation on ice with occasional mixing, the sam-
ples were spun at 13,000 3 g for 15 min at 4 °C, and the resulting
supernatants were stored at 270 °C. EMSA was performed by using as
a probe the double-stranded 22-base pair NF-kB consensus oligonucleo-
tide indicated above, which was labeled with DIG using the labeling kit
from Boehringer Mannheim. The nuclear extracts (5 mg of protein) were
assayed for kB binding activity using the DIG gel shift assay kit (Boeh-
ringer Mannheim, GmbH). The reactions were performed in 15 ml of
binding buffer (20 mM Tris-HCl, pH 7.5, 50 mM KCl, 1 mM EDTA, 1 mM
DTT, 0.1% (v/v) Nonidet P-40, 6% glycerol) and allowed to proceed for 20
min at room temperature. For competition assays, binding reactions
were performed in the presence of the unlabeled oligonucleotide (100-
fold molar excess) for 20 min at room temperature. Supershift assays
including anti-p50 and anti-p65 were carried out as described previ-
ously (46). The samples were finally electrophoresed on 5% polyacryl-
amide native gels at 4 °C in 0.253 TBE.
RESULTS
Calcineurin Is Present in Neutrophil Lysates—CN is a well
characterized phosphatase that plays an important role in T
cell activation pathways (1–4). In this work we have charac-
terized the presence of CN activity and immunoreactive CN
protein in human neutrophils. In crude neutrophil lysates,
specific CN activity was observed, and a linear appearance of
product during the assay was obtained in the range of 20–75 mg
of lysate proteins (Fig. 1A). The time course of CN activity is
shown in Fig. 1B. Clearly, 32P release increased linearly along
assay time until 15 min, and then a slow activity was found.
Fig. 1 (inset) illustrates an immunoblotting analysis of CN
expression in lymphocytes (lane 1) and different amounts of
human neutrophil lysates (lanes 2–4). We used an antiserum
that recognizes both the A (59 kDa) and B (19 kDa) chains of
CN, confirming that both subunits are expressed in human
neutrophils. As shown, neutrophil CNB migrates as a 16-kDa
band in SDS-polyacrylamide gels, and it is detected along with
a predominant CNA band migrating at 59 kDa. A third band,
detected at 57 kDa in lymphocytes extracts, is probably a
proteolytic fragment of CNA generated during preparation of
the cell lysates. In some preparations of neutrophil lysates, a
similar band of 55–57 kDa was also found (data not shown).
Next experiments were addressed to analyze the regulation of
CN activity in crude neutrophil lysates. Fig. 2 illustrates that
the dephosphorylation of the CN-specific substrate peptide by
crude neutrophil lysates was Ca21-dependent, as well as insen-
sitive to okadaic acid, a potent and specific inhibitor of phos-
phatases 1A and 2A (reviewed in Ref. 47). When 500 nM oka-
daic acid was included in the assays, nearly all of the remaining
phosphatase activity was Ca21-dependent and could be elimi-
nated by substituting 5 mM EGTA for Ca21 (Fig. 2). In contrast,
the okadaic acid-sensitive component was resistant to EGTA,
which is consistent with the reported Ca21 independence of
phosphatases 1A and 2A (17). CN activity was abrogated in
nominally calcium-free medium and in the presence of a known
inhibitor of calmodulin, trifluoroperazine (48). However, triflu-
oroperazine did not inhibit calcium-independent, okadaic acid-
sensitive phosphatases from neutrophil lysates (Fig. 2). Taken
FIG. 1. Specific dephosphorylation of a synthetic peptide substrate by crude neutrophil lysates. Calcineurin phosphatase activity was
measured as indicated under “Experimental Procedures.” Reaction mixtures contained 2 mM 32P-labeled phosphopeptide and 500 nM okadaic acid
in a total volume of 60 ml of assay buffer C. A, calcineurin activity was assayed using increasing amounts of neutrophil lysates during 15 min of
incubation at 30 °C. B, calcineurin activity was assayed during the indicated times with 50 mg of protein from neutrophil lysates. Inset,
immunoblotting analysis of calcineurin expression. Proteins were resolved by SDS-PAGE (12% polyacrylamide gel), transferred to nitrocellulose,
and probed with an antiserum that recognizes both the A and B chains of calcineurin. Lane 1, blood human lymphocytes (50 mg of protein); lanes
2–4, crude neutrophil lysates (25, 50, and 100 mg of protein, respectively). Size markers are indicated on the left.
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together, these data indicate that a specific Ca21/calmodulin-
dependent phosphatase activity is present in the neutrophil
lysates.
Inhibition of Calcineurin Activity in Isolated Neutrophils
Treated with Immunosuppressive Drugs—As previously indi-
cated (1–4), CsA and FK 506 can now be used as tools to
elucidate the participation of CN on signal transduction pro-
cesses. To assess whether treatment with these drugs inhibits
CN activity, neutrophils were incubated with different concen-
trations of FK 506 and CsA for 2 h, and phosphatase activity
was measured in cell lysates. Both agents effectively inhibited
Ca21-dependent phosphatase activity, as shown in Fig. 3.
These results indirectly suggested that the drug-sensitive
phosphatase present in neutrophils is CN. Furthermore, in
drug titration experiments both FK 506 and CsA inhibited CN
activity in a concentration-dependent fashion. IC50 values de-
termined for CN inhibition were approximately 0.5 ng/ml for
FK 506 and 5 ng/ml for CsA. This greater sensitivity to FK 506
than to CsA exhibited by neutrophil CN is similar to that
previously described for lymphocyte CN (1–4).
Effect of Oxidants on Calcineurin Activity—As previously
indicated, there is a clear relationship between the oxidative
stress and activation or suppression of transcription factor
activity (27–29). Since it has been shown that H2O2 suppresses
the transcriptional activation of NF-AT (35) and that NF-AT is
able to directly interact with CN (18, 19), we have explored
whether H2O2 could alter CN activity. Fig. 4 illustrates that
preincubation of neutrophils with H2O2 alone had no effect on
this phosphatase. However, the preincubation of cells with
AMT, an inhibitor of catalase, for 30 min and the further
addition of H2O2 produced a clear decrease in CN activity.
These data suggest that intracellular catalase in neutrophils
(49) diminishes the effective concentration of exogenously
added H2O2 and also indicate a potential protective role of
catalase against CN inactivation. The preincubation of cells
with AMT/H2O2 and PDTC, an antioxidant, partially amelio-
rated the inhibitory effect of H2O2 on CN activity. Neither AMT
nor PDTC added by themselves had any effect on CN activity.
The antioxidant action of PDTC against AMT/H2O2 inhibition
was found to occur only when equimolar concentrations of
H2O2 and PDTC were used; at 500–1000 mM H2O2 the prein-
cubation with 100 mM PDTC was without effect (data not
shown). A similar inhibitory effect of AMT/H2O2 on CN activity
was observed to occur in isolated human lymphocytes. The
treatment of these cells with 500 mM H2O2 or 50 mM pV(phen)
for 1 h resulted in a marked decrease in CN activity (54 and
43% inhibition after H2O2 and pV(phen)-treatment, respective-
ly). To explain this inhibitory effect of H2O2 on CN activity two
possibilities may be raised: (i) H2O2 alters the CN polypeptide
structure, and (ii) H2O2 damages CN prosthetic group struc-
ture. To test the first hypothesis, lysates from neutrophils
previously incubated with AMT and H2O2 were analyzed by
immunoblotting using a specific CN antibody. Fig. 5 shows that
these agents did not alter the ability of the A and B subunits to
be recognized by the anti-calcineurin antibody, suggesting that
the CN protein structure remained intact. However, the mod-
ification of prosthetic groups associated with the catalytic cen-
ter of CN remains a possibility. Previous data (50) describe a
protective role of superoxide dismutase on partially purified
CN from brain, suggesting that the environment redox can
alter the structure of Fe-Zn center of CN in a reversible man-
ner. In agreement with this possibility we have observed (Fig.
6) that the inhibition of CN by H2O2 in a neutrophil cell-free
system can be partially reversed by the further addition of
Fe21, DTT, or ascorbate, all of which act as reductants. A
FIG. 2. Effect of calcium, okadaic acid, and trifluoroperazine
on calcineurin activity from crude neutrophil lysates. Reaction
mixtures contained 20 ml of crude neutrophil lysate (80 mg of protein),
2 mM 32P-labeled phosphopeptide, and 40 ml of assay buffer. Other
additions were as follows: 0.1 mM CaCl2, 5 mM EGTA, 500 nM okadaic
acid (OA), or 200 nM trifluoroperazine (TFP), as indicated. CN activity
was assayed during 15 min at 30 °C. Phosphatase activity is expressed
as picomoles of phosphate released per min per mg of protein.
FIG. 3. Calcineurin phosphatase activity in CsA and FK 506-
treated neutrophils. Neutrophils (7 3 106 cells/ml) were incubated in
1 ml of incubation medium with the indicated doses of CsA and FK 506
for 2 h at 37 °C. Then the cells were harvested and washed, and the
pellet was lysed in buffer B. Calcineurin activity was assayed in the cell
lysates (80 mg of protein) as indicated under “Experimental Proce-
dures.” Phosphatase activity is expressed as picomoles of phosphate
released per min per mg of protein. Three experiments were performed
with similar results.
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previous report on the protective effect of these agents was
documented in a partially purified CN assay activity from
brain (50). Thus, our results are more consistent with a revers-
ible modification of the catalytic center of CN elicited by H2O2.
H2O2 rapidly diffuses away from and into cells. In order to
analyze the ability of neutrophils to internalize exogenous
H2O2, intracellular oxidant levels were monitored by meas-
uring the fluorescence of H2DCFDA, a highly fluorescent probe
sensitive to peroxides (51). Cells labeled with H2DCFDA dis-
played a significant increase in DCF fluorescence upon incuba-
tion with H2O2 (154.5 6 3.2 fluorescence units in 100 mM
H2O2-treated cells versus 12.7 6 1.1 units in control cells). In
other experiments, the treatment of neutrophils with a variety
of physiological and pharmacological stimuli revealed that
agents that promoted an increase of intracellular H2O2 also
induced a dose-dependent inhibition of CN activity in human
neutrophils. Notably, both tumor necrosis factor-a (50 ng/ml)
and interferon-g (50 units/ml) elicited an inhibition of CN ac-
tivity of about 25% after 2 h of treatment. Increased times of
tumor necrosis factor-a treatment (e.g. 8 h) resulted in an
enhanced inhibitory effect (of about 35%) on CN activity. How-
ever, LPS (100 ng/ml), platelet-activating factor, or glucocorti-
coids were without effect on CN activity (data not shown).
To investigate whether the H2O2 effect was specific, we also
analyzed the CN activity with a new peroxovanadium com-
pound, pV(phen), which causes intracellular oxidative stress
and induces strong protein tyrosine phosphorylation (37). The
treatment of neutrophils with pV(phen) caused a dose- and
time-dependent inhibition of CN activity (Fig. 7). After 60 min
of incubation of the cells with 50 mM pV(phen), an inhibition of
about of 60% was observed, with an apparent IC50 of about 30
mM. Therefore, we provide evidence that the observed inhibition
of CN by H2O2 could be the result of oxidative stress. Under
these conditions (e.g. in the presence of H2O2 and pV(phen)),
the cell viability was determined to be about 90%, and hence
significant cytotoxic effects can be ruled out. Also, a strong
FIG. 4. Inhibition of calcineurin activity in neutrophils
treated with hydrogen peroxide. Neutrophils (7 3 106 cells/ml)
were incubated at 37 °C under the following conditions: with 100 mM
H2O2 alone (l); preincubated with 25 mM AMT for 30 min and then
with 100 mM H2O2 (f); preincubated with 25 mM AMT for 30 min, then
100 mM PDTC for 10 min, and finally treated with 100 mM H2O2 (). The
times of incubation with H2O2 are indicated. Incubation of cells was
stopped at different times, and calcineurin activity was assayed in cell
lysates (80 mg of protein) as indicated under “Experimental Proce-
dures.” Phosphatase activity is expressed as picomoles of phosphate
released per min per mg of protein. Means 6 S.E. values from three
separate experiments performed in triplicate are presented.
FIG. 5. Immunoblot analysis of the stability of calcineurin
structure. Neutrophils (1 3 107 cells/ml) were incubated under the
following conditions: lane 1, no additions (control); lane 2, 0.5 mM H2O2
for 30 min; lane 3, 25 mM AMT for 30 min and then 0.5 mM H2O2 for 30
min; lane 4, 100 mM PDTC for 10 min and then 0.5 mM H2O2 for 30 min;
lane 5, 25 mM AMT for 30 min and then 100 mM PDTC for 10 min; lane
6, 25 mM AMT for 30 min followed by 100 mM PDTC for 10 min and then
0.5 mM H2O2 for 30 min; lane 7, T cells without treatment. Proteins
were resolved by SDS-PAGE (12% polyacrylamide gel), transferred to
nitrocellulose, and probed with a polyclonal antiserum against cal-
cineurin. The band at 28 kDa is probably a proteolytic fragment of
calcineurin A generated during the preparation of cell lysates.
FIG. 6. Reversibility by Fe21, ascorbate, and dithiothreitol of
H2O2-inhibited calcineurin in neutrophil lysates. Cell lysates (80
mg of protein) were incubated with 5 mM AMT for 5 min, followed with
100 mM H2O2 for 10 min. When present, 0.5 mM ferrous sulfate (Fe
21),
5 mM DTT, or 5 mM sodium ascorbate (Asc) were added, either alone or
altogether, for 20 min before the peptide substrate for the assay of
calcineurin activity was added. Phosphatase activity is expressed in
relation to the value obtained without cell treatment (Control).
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increase in the intracellular phosphotyrosine levels was de-
tected in neutrophil lysates after incubation of the cells with
pV(phen),2 in agreement with previous reports on B lympho-
cytes (37).
EMSA analyses were carried out in order to test whether the
changes in CN activity promoted by H2O2 were accompanied by
an alteration of the DNA binding activity of two transcription
factors, namely NF-AT and NF-kB. No binding activity was
detected on neutrophil nuclear extracts when the NF-AT probe
was used. However, activated NF-kB was detectable as a
uniquely positioned band in assays of nuclear extracts from
human neutrophils stimulated with LPS (1 mg/ml) (Fig. 8). On
the basis of the results from McDonald et al. (46) and of super-
shift assays using anti-p50 and anti-p65 antibodies (data not
shown), we interpreted the upper band as corresponding to the
activated form of NF-kB (i.e. the p50/p65 tetramer). Gel retar-
dation analysis of extracts from neutrophils stimulated with
LPS and different doses of H2O2 demonstrated that H2O2 se-
lectively inhibits the activation of NF-kB, resulting in a grad-
ual decrease of the intensity of the p50/p65 band, as H2O2 was
increased. As a negative control, we also analyzed the effect of
CsA (1 mg/ml) (lane 1). In agreement with previous data from
other cell lines (1–4), the p50/p65 band was only barely detect-
able in extracts from CsA/LPS-treated neutrophils. These re-
sults are consistent with an NF-kB activity regulated by CN in
neutrophils, in agreement with previous reports (20–22). Pres-
ent data concerning H2O2 inhibition of CN in neutrophils and
lymphocytes suggest that previous evidence on H2O2-stimu-
lated NF-kB functional activity (27, 29) can be interpreted as
the result that peroxides, above a threshold level, are able to
bypass the CN modulatory step and regulate transcription
factors activity independently of CN.
DISCUSSION
Only a few reports concerning CN in neutrophils and pre-
senting indirect evidence of its presence in these cells have
been published (23–26). All of them deal with neutrophil mo-
tility on vitronectin and its inhibition by CsA and FK 506
(23–26), a couple of well known inhibitors of CN activity. Here
we have analyzed accurately, using a synthetic peptide corre-
sponding to the phosphorylation site of the RII subunit of cyclic
AMP-dependent protein kinase, the presence of CN in human
neutrophils. Lysates from neutrophils dephosphorylate this
substrate in a dose- and time-dependent manner. CN activity
in neutrophils is insensitive to okadaic acid, whereas other
phosphatases (e.g. 1A and 2A) are sensitive to this inhibitor
(47). In the presence of okadaic acid the CN activity from
neutrophil lysates is both Ca21-dependent and Ca21-sensitive
to inhibition by trifluoroperazine, a calmodulin inhibitor. In
addition, we present evidence that two well known immuno-
suppressants and inhibitors of CN activity in lymphocytes, CsA
and FK 506 (1–4), potently depressed CN activity in neutro-
phils. It is well accepted that CN plays an important role as a
prominent component of the calcium signaling pathway in T
cells, by acting as an obligatory step between immunosuppres-
sive drugs (e.g. CsA and FK 506) and some transcription factors
(e.g. NF-AT and NF-kB) (1–4, 20, 21). The mechanism by which
CN activates NF-AT seems rather complex. It has been shown
that the coexpression in transfected cells of the activated CN
and activated p21ras could mimic T cell receptor signaling dur-
ing NF-AT induction, both acting as cooperative partners dur-
ing T cell activation (52). Also, recent data show that CN forms
a complex with cytosolic NF-AT4 (an isoform of NF-AT), which
is transported to the nucleus where CN continues to dephos-
phorylate NF-AT4 (53). On the other hand the important role of
ROI in the regulation of some transcription factors, mainly
FIG. 7. Inhibition of calcineurin activity in neutrophils incubated with pV(phen). A, neutrophils (7 3 106 cells/ml) were treated with
50 mM pV(phen) at 37 °C at different times. B, neutrophils (7 3 106 cells/ml) were treated with different pV(phen) concentrations at 37 °C for 1 h.
Calcineurin activity was assayed in cell lysates (80 mg of protein). Phosphatase activity is expressed as picomoles of phosphate released per minute
per mg of protein. Means 6 S.E. values from three separated experiments performed in triplicate are presented.
FIG. 8. Reduced binding activity of NF-kB in H2O2-treated hu-
man neutrophils. Binding activity of nuclear proteins (5 mg) from
human neutrophils to a digoxigenin-labeled oligonucleotide containing
the consensus NF-kB binding sequence was assessed by EMSA (see
“Experimental Procedures”). The cells were untreated (lanes 1 and 7) or
incubated with H2O2 (0.1, 0.5, 1, and 2 mM; lanes 3, 4, 5, and 6,
respectively) for 15 min prior to LPS stimulation (1 mg/ml) for 10 min.
Before treatment with H2O2, cells were incubated with AMT (25 mM) for
30 min. CsA (1 mg/ml, lane 9) was added 30 min prior to LPS stimula-
tion (1 mg/ml) without AMT. A control including a 100-fold excess of
unlabeled oligonucleotide in the reaction performed with nuclear ex-
tracts from LPS-treated human neutrophils is also shown (lane 10). The
figure shows a representative experiment out of three carried out with
identical results.
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NF-kB, is stressed by its activation in response to the addition
of H2O2 (29), although doubts that it represents a universal
phenomenon has been raised (30–32, 34). Moreover, an inverse
relationship between ROI and NF-AT has also been pointed
out, since low levels of H2O2 can actively suppress the tran-
scription activity of NF-AT and the expression of interleukin-2
mRNA (35). These studies indicate that CN is a key component
of the T cell signal transduction cascade and that oxidative
signals can positively or negatively regulate transcription fac-
tor activity (54, 55). However, a deep knowledge of the molec-
ular mechanism connecting both components (i.e. CN and oxi-
dative signals) is lacking. We present here evidence for the first
time that human neutrophils treated with H2O2 or pV(phen)
exhibit a suppression of CN activity and that H2O2 effect re-
quired the previous inhibition of catalase activity. Only when
catalase was inhibited by AMT a clear decrease of CN activity
in the presence of exogenous H2O2 was observed. As expected,
we have observed that the preincubation of neutrophils with
the antioxidant PDTC cancelled the inhibition of CN activity by
H2O2. As a preliminary effort toward the elucidation of the
functional consequences of H2O2-dependent CN inhibition, we
focused our attention on the transcription factor NF-AT as a
potential target. However, we were unable to find any NF-AT
DNA binding activity in nuclear extracts from neutrophils
(data not shown). This fact closely agrees with previous results
from immunoblotting analysis pointing out the absence of
NF-AT proteins in neutrophils (56). Subsequent experiments
were thus addressed to analyze whether H2O2-dependent CN
inactivation could affect NF-kB activation. Conflicting results
have been published on the presence or absence of NF-kB in
human neutrophils. Browning et al. (57) did not observe any
NF-kB activation in these cells. However, Cassatella and co-
workers (46) described the presence of NF-kB subunits as well
as the existence of NF-kB DNA binding activity in human
neutrophils. We have followed the methodology described by
the latter authors, with minor modifications, and have detected
NF-kB DNA binding activity in fresh human neutrophils, to-
gether with its inhibition by H2O2. These data indicate that
NF-kB activation is modulated by CN activity in human
neutrophils.
Indirect evidence that CN is an enzyme sensitive to its redox
environment has been reported, based on the fact that super-
oxide dismutase protects CN from spontaneous inactivation in
brain crude extracts (50). This inactivation was interpreted as
resulting from oxidative damage of the Fe-Zn active center of
CN (50). Since there is a good evidence that CN is an Fe-Zn-
containing enzyme (16), the hypothetical mechanism that can
be proposed for this oxidative damage is that H2O2 and pV-
(phen) could modify the redox state of the Fe-Zn center in the
catalytic site and thereby inactivate the enzyme. This mecha-
nism is in agreement with the observation that the reactivation
of H2O2-inhibited neutrophil CN requires the addition of re-
ducing agents, such as Fe21, ascorbate, and DTT (Fig. 6), as it
was also previously demonstrated for a preparation of CN from
brain (50). The observed inhibition of CN in intact neutrophils
by oxidants, such as H2O2 and pV(phen), represents a novel
mechanism of action for these agents. The pV(phen) molecule
presents a dual activity, acting both as an intracellular oxidant
and as an inhibitor of phosphotyrosine phosphatase (37). Evi-
dence also has been presented that the activities of both protein
tyrosine phosphatase and protein phosphatase 2A were re-
duced after H2O2 treatment of intact Jurkat T cells (58). Pre-
viously it has been described that CN has a regulatory phos-
phorylation site that is phosphorylated by the Ca21-
independent form of calmodulin-kinase II. This phosphorylated
CN exhibits a 50% decrease in its Vmax and 2-fold increase in
the Km values (59). Thus, a hypothetical model in which oxi-
dants modulate CN activity through phosphorylation of its
regulatory site can therefore be postulated in the light of pres-
ent data.
An apparent discrepancy between CN inhibition by H2O2
and other oxidant species, described here, and the protection
exerted on CN by superoxide dismutase (50), which converts
anion superoxide on H2O2, may be raised. In this context,
however, the role of catalase and peroxidases, as detoxicant
enzymes that degradate H2O2, should be introduced. These
enzymes are also mutually protective, and therefore synergis-
tic, when both O2
. and H2O2 are being made. In fact, experi-
mental evidence (Fig. 4) illustrates the absence of effect by
exogenous H2O2 added alone and the requirement of AMT to
inhibit intracellular catalase and to detect H2O2-dependent CN
inactivation. These data indirectly provide the notion of cata-
lase as an additional protecting enzyme for CN against ROI
inactivation. The implication of this suggestion is that, under
normal physiological conditions, the cellular CN may be rela-
tively less susceptible to molecular oxidative damage by ROI.
Conversely, in pathological process, such as inflammation and
reperfusion injury, or situations characterized by an inhibition
of ROI-detoxicant enzymes, the CN inactivation by oxidant
species may take place, and it could be a relevant process in the
context of the oxidative stress state.
In summary, available evidence indicates that CN activity is
a redox-sensitive step in cellular signaling cascades and sug-
gests that the inhibition of NF-AT from lymphocytes (35) and
NF-kB from neutrophils (present work) by H2O2 is elicited
through inactivation of CN.
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